Summer is the perfect time to prioritize proactive health measures. The Lymphedema Prevention Program (LPP) is designed to help healthcare providers implement effective surveillance and intervention strategies for patients at risk of developing Breast Cancer-Related Lymphedema (BCRL). By detecting and treating lymphedema early, LPP supports improved patient outcomes and quality of life. Discover how this program can enhance your practice and benefit your patients this summer. Learn more about LPP: https://ow.ly/FyX550SGAkt #LymphedemaPrevention #BreastCancerCare #HealthcareInnovation #SummerHealth
About us
ImpediMed Limited is the world leader in the development and distribution of medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the noninvasive clinical assessment and monitoring of fluid status. ImpediMed’s primary product range consists of a number of medical devices that aid surgeons, oncologists, therapists and radiation oncologists in the clinical assessment of patients for the potential onset of secondary lymphoedema. Pre-operative clinical assessment in cancer survivors, before the onset of symptoms, may prevent the condition from becoming a lifelong management issue and thus improve the quality of life of the cancer survivor. ImpediMed had the first medical device with an FDA clearance in the United States to aid health care professionals in the clinical assessment of secondary lymphoedema of the arm and leg in female and male cancer patients.
- Website
-
http://www.impedimed.com
External link for ImpediMed
- Industry
- Medical Equipment Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Carlsbad, CA
- Type
- Public Company
- Founded
- 1999
- Specialties
- Lymphedema, Fluid Status, Body Composition, Tissue Analysis, Breast Cancer, and Heart Failure
Locations
-
Primary
5900 Pasteur Ct. Suite 125
Carlsbad, CA 92008, US
-
Unit 1, 50 Parker Court
Pinkenba, Queensland 4008, AU
-
Adrianoupoleos 24, 3os orofos
Kalamaria, Thessaloniki 55133, GR
Employees at ImpediMed
-
Steven Chen, MD, MBA
Surgical Oncologist | Chief Medical Officer | Biotechnology | Medical Device
-
Aaron Ogilvie
-
Richard Hines
Senior Manager of Regulatory Affairs
-
Amy Beth Gerzog
Always committed to empowering medical professionals to make smarter purchasing decisions without sacrificing patient care. Passion for animals, our…
Updates
-
🎧 Tune into the latest episode of the Real Pink Podcast by Susan G. Komen, featuring our CMO, Dr. Steven Chen, and patient advocate Kathy Lahr. They explore essential strategies for managing breast cancer-related lymphedema, offering support and insights for survivors and caregivers. Learn about the latest advancements in early detection and effective management techniques that can make a real difference in patients' lives. Don't miss this opportunity to gain valuable knowledge and empower those affected by lymphedema. Listen now: https://ow.ly/b40B50SGAiM #BreastCancerAwareness #LymphedemaAwareness #RealPinkPodcast #ImpediMed
The Real Pink Podcast: What to Know About Breast Cancer-Related Lymphedema
impedimed.com
-
📢 Great news! SOZO®'s BIS technology continues to expand its coverage with American Medicare and a growing number of private payors. This ensures more patients can access early detection and effective management of lymphedema. Learn how integrating SOZO® into your practice can enhance patient outcomes and streamline reimbursement processes. Reach out to a specialist at ImpediMed for personalized support. Discover more: https://ow.ly/TGU650SGAhr #LymphedemaPrevention #Reimbursement #HealthcareInnovation #PatientCare
-
-
While breast cancer treatments save lives, they can lead to lymphedema in up to 20% of patients. Dr. Steven Chen, our CMO, discusses on MedPage Today's KevinMD.com how early detection and innovative strategies can significantly improve survivors' quality of life. Discover how technologies like bioimpedance spectroscopy (BIS) are transforming care and reducing the burden of BCRL. Learn more about proactive measures and patient education that can make a real difference. 🔗 Read the full article: https://ow.ly/qi4L50SCu1Z #BreastCancerAwareness #LymphedemaPrevention #CancerSurvivorship #HealthcareInnovation
Kevin MD: Navigating the challenges of breast cancer-related lymphedema
impedimed.com
-
📢 New Article Published! The latest research in the Annals of Surgical Oncology highlights the critical importance of monitoring breast cancer patients for lymphedema for at least three years post-treatment. Early detection using bioimpedance spectroscopy (BIS) can prevent progression to chronic lymphedema, ensuring better patient outcomes. “Breast cancer related lymphedema can develop years after cancer treatment is concluded and can progress from the subclinical stage, where intervention is possible to reverse progression, to chronic lymphedema, where this can become a lifelong condition” says Dr. Steven Chen, co-author of the article and Chief Medical Officer, ImpediMed. Read more about these important findings and their implications for patient care in our latest news release: https://ow.ly/zVa650SCMVx #LymphedemaAwareness #BreastCancerCare #EarlyDetection
Additional Data Published in “Annals of Surgical Oncology” Recommends Extended Monitoring of Lymphedema for Breast Cancer Patients
impedimed.com
-
🎥 Didn’t get a chance to attend our latest webinar on “Preventing Chronic Breast Cancer-Related Lymphedema: Practical Insights for Operationalizing a Lymphedema Surveillance Program”? Now you can catch up anytime! Join Dr. Steven Chen, Dr. Allison DiPasquale, and Dr. Manpreet Kohli as they share their expertise on early detection, clinical guidelines, and effective implementation strategies for a comprehensive Lymphedema Surveillance Program. Stay ahead in lymphedema care and support your patients with the latest knowledge and best practices. Watch the full webinar here: https://ow.ly/ERgL50SA176 #LymphedemaCare #BreastCancerSupport #WebinarRecording #HealthcareInnovation
Preventing Chronic Breast Cancer-Related Lymphedema: Practical Insights for Operationalizing a Lymphedema Surveillance Program
impedimed.com
-
New 2024 Clinical Practice Guideline Update! The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Survivorship have been updated to V.1.2024. The guidelines continue to recommend bioimpedance spectroscopy as a key technology for survivorship care. Discover the latest updates and comprehensive information in the NCCN Guidelines® by visiting NCCN.org. Learn More about bioimpedance spectroscopy technology from ImpediMed: https://ow.ly/Xh6050Syc13
-
-
We're excited to share the Lymphatic Education & Research Network (LEARN)'s latest report on the state of lymphedema care in the U.S. This comprehensive report sheds light on current knowledge and the importance of early detection, including the role of bioimpedance spectroscopy (BIS). This resource is vital for healthcare professionals, advocates, and policymakers to drive awareness and improve care standards. Access the report and the Communications Toolkit to join the advocacy efforts. #LymphedemaAwareness #BIS #EarlyDetection #LymphaticHealth
Read the full Report and download the Communications Toolkit here: https://lnkd.in/ex4bM5wU We are excited to announce the release of our groundbreaking report that provides the state of lymphedema knowledge and care in the United States. This first-of-its-kind report addresses the critical shortage of public health data regarding lymphedema's impact and equips you with discussion points to advocate. Download our Communications Toolkit to share the report with Advocates, Healthcare Professionals, and Policymakers. Maximizing the report's reach is crucial for advancing the future of lymphatic disease care and awareness.
-
-
🩺 The critical role of nurse navigators in lymphedema care is highlighted in this insightful article from Oncology Nursing News. Nurse navigators ensure timely and comprehensive care, addressing the unique challenges patients face with lymphedema. Their dedication helps in early detection, effective intervention, and continuous support, significantly improving patient outcomes. Read more about how these healthcare heroes are transforming lymphedema care: https://lnkd.in/gD8r3y3y #LymphedemaCare #NurseNavigators #HealthcareHeroes #PatientSupport
Nurse Navigators Aid in Timely and Comprehensive Lymphedema Care
oncnursingnews.com